Mentor Capital Reports 3rd Quarter 2017 10-Q

Increased Cash, Investments, and Revenue Reported by Medical Marijuana and Cannabis Company (For Immediate Release, November 10, 2017) SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) announced that it has filed its quarterly 10-Q filing for the third quarter ended September 30, 2017 with the Securities and Exchange Commission. For the quarter ended September 30, 2017,

SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) announced that it has filed its quarterly Form 10-Q filing for the second quarter ended June 30, 2017 with the Securities and Exchange Commission. For the quarter ended June 30, 2017, Mentor had revenues of $764,549 and gross profit of $268,664 with a resulting net loss attributable to

Mentor Capital Funds $2.4M in Five YTD Cannabis Investments

First Quarter 10-Q Filing Reports $3.7M Raise and $1.7M Cash for Marijuana and Cannabis M&A Leader SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) announced that it has filed its quarterly 10-Q filing for the first quarter ended March 31, 2017 with the SEC. The Company reports that for the quarter ended March 31, 2017, Mentor

Mentor Capital Again Invests in G FarmaLabs Success

Wall Street Mentor and Cannabis Leader Bridge Money into the MJ Market SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) is happy to announce that it has extended its funding to G FarmaLabs by an extra 20% with an additional loan on top of last month’s million dollar investment in this global cannabis leader founded under

Mentor Capital Pays $300,000 Early to Long-Time Shareholders

3,000,000 Series B Warrants Redeemed Now Prior to May 2018 Due Date. SAN DIEGO, Mentor Capital, Inc. (OTCQB:MNTR) announces that early shareholders who together also hold approximately 3,000,000 Series B Warrants are having the 10 cent per warrant redemption payment for those warrants voluntarily paid out now by the Company approximately one-year in advance of

Mentor Capital Seeds Glaucoma – Cannabis Venture

Cannabis Venture Contract Signed for Medical Marijuana Application to Glaucoma (For Immediate Release, April 13, 2017) SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) announces it has initiated funding for its GlauCanna venture for the use of medical marijuana in the treatment of glaucoma patients. Mentor will provide funding and business management for any commercial development

SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) announced it has continued adding over 1,000 shareholders per month bringing its base of active shareholders who have Mentor shares in a brokerage account to 10,000 from 6,000 just at year end and 3,000 only three months earlier. “This extraordinary strong shareholder base allows Mentor to provide an

Mentor Capital Book Value Up 66% to $5.6M Today, in 2016 10-K

G Farma, GWPH, Bhang and Cash Total $5.4M for Marijuana and Cannabis M&A Leader SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) announced that it has filed its annual 10-K filing for the year ended December 31, 2016 with the SEC. The Company reports that for the year ended December 31, 2016 Mentor had revenues of

SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) announces it has closed and paid in cash and stock a $1.0 million multi-faceted financing program for G FarmaLabs Limited. The initial Mentor financing is structured to provide funding for real estate and working capital. G Farma has also been provided Mentor public shares to participate in any